AbbVie Inc
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
56/100
Moderate Influence
$21.8M
Total Lobby Spend
6
Policy Issues
9
Lobbyists
1
Revolving Door
AbbVie Inc reported $21.8 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Federal Communications Commission
Dept of Defense
White House
US House of Representatives
Dept of Commerce
Federal Energy Regulatory Commission
Environmental Protection Agency
Dept of Education
Dept of Energy
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | K&L Gates LLP | TAXMEDGOV | 4 | $883K |
| 2020 Apr-Jun | Squire Patton Boggs LLP | CPTHCRMED+2 | 4 | $747K |
| 2020 Jul-Sep | Holland & Knight LLP | HCRPHA | 4 | $726K |
| 2020 Oct-Dec | Covington & Burling LLP | CPTHCRGOV | 1 | $937K |
| 2021 Jan-Mar | K&L Gates LLP | GOVMED | 4 | $1.4M |
| 2021 Apr-Jun | Squire Patton Boggs LLP | PHACPT | 3 | $1.1M |
| 2021 Jul-Sep | Akin Gump LLP | CPTPHA | 4 | $933K |
| 2021 Oct-Dec | Holland & Knight LLP | HCRMED | 4 | $938K |